lesson 2.5 workbook -...

W o r k b o o kLesson 2.5 63

LESSON 2.5 WORKBOOK

Throughout this unit, we’ve discussed the basic struc-tures and functions of the major cells that make our nervous systems: neurons and glia. In this lesson, we’ll investigate what happens when these functions are compromised by disease or injury.

What if there are problems conducting action potentials?

We can make several predictions about when and how problems in conducting action potentials might occur. For example, action potential conduction will be affected if:

• The voltage-gated Na+ channels don’t function properly.• Myelination is abnormal.

If any of the above happens, we can predict what effect it will have on the neuron:

• If the voltage-gated Na+ channels don’t function properly, the axon will be unable to gener-ate action potentials properly.

• If myelination is abnormal, then the axon will be unable to synchronize conduction of the action potential and signaling may fail completely.

Diseases of axonal conduction

Let’s now investigate three diseases of action potential conduction in more depth:

• Congenital analgesia• Multiple Sclerosis (MS)• Charcot-Marie Tooth Disease (CMTD)

____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What can go wrong?


LESSON READINGCongenital Analgesia – Case study of Gabby

Gabby is 5 years old (Figure 27). Her parents have consulted with many specialists throughout their daughter’s life in hopes of finding an explanation for why their daughter behaves so strangely.

Gabby’s parents first knew that something was wrong when Gabby was only a few months old. Like other babies her age, she was teeth-ing. But unlike other babies, who would cry in pain, Gabby never cried. One morning, her father noticed that she had been chewing on her fingers so much that they were bleeding, but again, she never cried. Her mother described Gabby’s hand as “mangled and nasty, like raw hamburger”. After consulting with several doctors, Gabby’s parents had all of her baby teeth removed so that she could not further harm herself.

When Gabby was a year old, her mother noticed a white spot on her left eye. She thought it was just something floating in Gabby’s eye, but in fact Gabby had somehow scratched her cornea. The doctor who treated Gabby told her mother that “In most patients, this type of wound would be so painful, they would not be able to open their eye”. To prevent Gabby from scratching her eye any more, the doctor stitched that eye closed. But, unable to feel pain, Gabby ripped out the stitches.

These are just two of the incidents that brought Gabby’s parents into see a neurologist for further ex-amination. The doctor diagnosed Gabby with congenital analgesia. Congenital analgesia is a very rare inherited disease in which children, usually from birth, cannot sense pain even though their other senses are normal. Like Gabby, children with this disease often suffer from oral damage, like biting off the tip of their tongue, and scratches to the cornea.

Researchers have learned that the disease can be caused by a mu-tation in the gene that codes for a voltage-gated Na+ channel. This voltage-gated Na+ channel (called SCN9A) is found specifically in the specialized receptors that detect pain called nociceptors. In a nor-mal person, when nociceptor dendrites detect a pain sensation, the SCN9A Na+ channel will amplify the signal so it reaches threshold and allows an action potential to fire. However, in patients with congenital analgesia this voltage-gated sodium channel doesn’t work and thus the input from the dendrites never reaches threshold so an action po-tential doesn’t fire (Figure 28).

Congenital analgesia is not fatal, but patients suffering from it will never lead a normal life. Because they can’t detect pain, they need to closely monitor their bodies for injuries and infections. Even so, the inability to feel pain causes complications that mean very few patients with this disease live to a normal life expectancy.

DEFINITIONS OF TERMS

Congenital analgesia – disease in which patients do not sense

pain.

For a complete list of defined terms, see the Glossary.

What are Gabby’s symptoms? What did her doctor diagnose her with?______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What is the neuronal defect in congenital an-algesia?________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What is the treatment for congenital analge-sia?______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Figure 27: Five year old Gabby.

Normal Pa)ent Congenital Analgesia

X

X Figure 28: Congenital analge-sia. Patients do not feel pain because a mutation in the voltage-gated Na+ channels in their nociceptors means an action potential cannot fire, so the nociceptors never detect any pain.

http://sites.tufts.edu/greatdiseases/student/glossary/


LESSON READINGMultiple sclerosis (MS) – Case study of Maria

Maria is 37 years old (Figure 29). She has been having reoccurring episodes of muscle weakness in her arms and legs. The weakness lasts for a week or two and then subsides. At other times she noticed numbness in different parts of her body. Since the episodes came and went, she did not think much of it until she started having changes in her vision. First, she noticed that she was experiencing double vision, and then she noticed that she was having problems seeing out of her left eye. It was at this point that Maria called her doctor.

Maria’s doctor started the appointment by reviewing Maria’s family history. Luckily, none of Maria’s ex-tended family had ever suffered from a neurological disease. She then gave Maria a thorough examina-tion. First, she checked her eye reflexes and noted that her left eye had a decreased pupillary reflex, which means it didn’t respond to a bright light by contracting. Next, she checked Maria’s sensitivity to touch sensation and found it was decreased in different parts of her body. The doctor ordered both an MRI to see if there were any abnormalities in Maria’s brain, and a spinal tap to see if there were any abnormal proteins in Maria’s cerebrospinal fluid. The MRI showed a couple of small areas in Maria’s brain where the myelin looked abnormal (called plaques), and the spinal tap detected a high level of antibodies in her cerebrospi-nal fluid. The doctor gave Maria a preliminary diagnosis of multiple sclerosis, but told her that to confirm the diagnosis; she would need to follow Maria’s condition and rule out any other neurological abnormality.

Multiple sclerosis (MS) can occur at any age, but is most commonly diagnosed between the ages of 20 and 40. The disease affects more women than men. MS is caused by damage to myelin within the cen-tral nervous system (Figure 30). The CNS myelin is damaged because the immune system makes antibodies against it, and the antibodies attack the myelin, causing inflammation. Repeat episodes of inflammation can occur anywhere in the brain, optic nerve and spinal cord. We think that some aspect of myelin’s structure must resemble an infectious agent that previously infected the patient. The body first made antibodies against the infection, but those antibodies then become confused and attack the patient’s own myelin. This is attack on self, causes an autoimmune disease.


Multiple sclerosis (MS) – disease in which myelin within the central

nervous system is damaged.


Figure 29: Maria, age 37.

A.

B.

Figure 30: Multiple sclerosis. (A) Multiple sclerosis is an autoimmune disease in which a patient’s T cells destroy the glial cells that myelinate CNS neurons. (B) MRI scans of patients’ brains with multiple sclerosis show areas of damaged myelin, appearing here as denser plagues. Regions close to the ventricles are commonly affected.

What are Maria’s symptoms? What did her doctor diagnose her with?______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What is the neuronal defect in multiple scle-rosis?________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What does the treatment for multiple sclero-sis hope to do?______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________



LESSON READINGThe symptoms of MS can vary based on the location of inflammation. The most common symptoms include disturbances in vision, weakness, numbness or abnormal sensations in the arms or legs, muscle spasms and loss of balance. The intensity of any episode and how long it lasts depends on the severity of the inflammation in the CNS. However many patients experience even long periods without any symp-toms, and during those stages they are said to be in remission. Most patients return near normal function while they are in remission. But over time and with more episodes, function gradually declines. Even so, most patients with MS remain able to walk and can function normally or with minor disability for 20 years or more after diagnosis. Patients at later stages of disease may require a wheelchair to get around. MS is a chronic disease that is currently incurable; treatment aims to slow the disease progression and lessen symptoms. Even so, patients with MS have normal, or almost normal, life expectancies.

Charcot-Marie Tooth Disease (CMTD) – Case study of Allison

Allison is sixteen years old (Figure 31). Recently she noticed that she is having a difficult time walking. Her feet and legs do not seem to be as strong as they were even just a year ago. Allison considers herself to be in good shape, but lately on her daily walks, she has been tripping frequently. She has also been having a hard time breathing. During her yearly physi-cal she mentioned these difficulties to her doctor.

Allison’s doctor asked questions about her family history. Allison knew that her uncle has a disease called Charcot-Marie Tooth Disease (CMTD). Her uncle’s disease was diagnosed when he was in his early 20s and it has made it difficult for him to walk and perform fine tasks with his fingers.

Concerned that Allison might be developing CMTD too, her doctor examined Allison’s lower legs carefully. He noticed that Allison’s legs look a bit like an inverted champagne bottle because she has lost a lot of muscle bulk in the lower legs (Figure 32). Allison’s doctor also tested her tendon reflexes and sensory perception. Given Allison’s family history and worried by her poor performance on these tests, the doctor also ordered electrodiagnostic tests to see how well Allison’s peripheral nerves were able to conduct an action potential.

The tests are done by placing electrodes on the skin. These electrodes produce a small electric shock which stimulates both sensory and motor nerves. A needle, inserted into the skin, measures the ability of Allison’s nerves to conduct an action potential in response to the small electric shock. Unfortunately, Al-lison’s readings on this test indicate that her axons are not conducting action potentials as quickly as they would in normal people.

Figure 31: Allison, age 37.

A.

B.

Figure 32: Charcot-Marie Tooth disease (CMTD). (A) CMTD is caused by damage to myelin in the peripheral nervous system. (B) “Stork legs” seen in CMTD are due to muscle wasting in the low-er part of the leg because innervation of skeletal muscles is defective.

What are Allisons symptoms? What did her doctor diagnose her with?__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What is the neuronal defect in CMTD?_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________


LESSON READINGGiven her family history, and her results on the electrodiagnostic test, Allison’s doctor diagnosed her with Charcot-Marie Tooth Disease (CMTD). CMTD is the one of the most common inherited neurological dis-orders. CMTD is commonly diagnosed when patients are in their teens or early twenties. CMTD is caused by damage to the myelin sheath around peripheral nerves (Figure 32). Usually, the motor nerves in the legs are affected first, causing lower leg weakness and muscle atrophy, as Allison saw. Sensory nerve degeneration causes a reduced ability to sense heat, cold, and feel pain. In later stages of the disease, similar symptoms may appear in the arms and hands as well as the legs. The severity of the symptoms is variable between patients. CMTD is not fatal and patients with most forms of the disease have normal life expectancies.

While there currently is no treatment, orthopedic shoes and braces may help patients to walk. Physical and occupational therapy are also helpful for many patients because therapy helps to maintain muscle strength.

You can watch a video of patients with CMTD online — click below or see this unit on the student website: ■ Video: Charcot-Marie-Tooth Disease: A patient’s perspective

What if there are problems with axonal transport?

We can make several predictions about when and how problems in transport will occur. For example, transport will be affected if:

• The transport motors don’t function properly.• The microtubule tracks are disturbed.• The supply of ATP to the neuron is compromised or if mitochondria are defective.

If any of the above happens, we can predict the effect on the neuron.

• If transport of organelles and mitochondria is affected, then the axon terminal will be unable to function.

• If transport of cytoskeleton is affected, then axonal structure and diameter will be abnormal.

Diseases of axonal transport

Let us now investigate three of these diseases in more depth:

• Hereditary spastic paraplegia (HSP)• Diabetic neuropathy• Alzheimer’s disease

For two of the three (diabetic neuropathy and Alzheimer’s disease) the disruptions to axonal transport oc-cur as a result of the disease, but are not its cause. Regardless, when axonal transport doesn’t function properly, neurons degenerate in all three diseases.

If you were going to design a drug to treat CMTD, what would you have that drug do?______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________


Charcot-Marie Tooth Disease (CMTD) – disease in which myelin

within the peripheral nervous system is damaged.


http://sites.tufts.edu/greatdiseases/student/neurological-disorders/nd-unit2/multimedia/cmtd-patient-perspective-video/



LESSON READINGHereditary spastic paraplegia (HSP) – Case study of Mitchell

Mitchell is 17 years old and recently noticed that he has begun to trip up frequently (Figure 33). As he paid more attention to why, he noticed that he was having difficulty raising his legs to walk. Since he thought this was odd, he mentioned it to his doctor during his yearly physical. His doctor asked him to stand up, and then lift just his toes. Mitchell had a really difficult time with it. The doctor prescribed physi-cal therapy and asked Mitchell to make another appointment if his symptoms got worse.

A year later, Mitchell’s problem had not got better. He felt the muscles in his legs were often weak and quite stiff. He also noticed that his sense of balance was not what it once had been. Sometimes his legs even felt numb. He called the doctor and went back for another appointment.

After many tests, including an MRI, Mitchell’s doctor diagnosed him with hereditary spastic paraplegia (HSP). HSP is characterized by progressive spasticity, defined as stiff or rigid muscles in the lower limbs. Patients can also experience bladder disturbances, and impaired sensations in the feet. HSP can develop at any age. Those patients who develop symptoms before the age of 35 have Type 1, and those patients who develop symptoms after 35 have Type 2. For Type 1 cases, spasticity of the lower limbs is greater than weakness of lower limbs so difficulty walking is not common. In Type 2 cases, muscle weakness, urinary symptoms and sensory loss are more severe.

Mitchell’s doctor referred him to a specialist who was studying the genetic causes of HSP. The specialist completed a genetic screen on Mitchell to determine if he was a carrier of the mutation his lab studied. As it turned out, Mitchell did carry a mutation within the specialist’s gene of interest, KIF5A.

KIF5A is a member of the kinesin family. Remember that Kine-sins are plus-end directed motor proteins that carry cargo from the cell body to the axon terminal. Research has demonstrated that mutations within the motor part of the KIF5A protein can cause HSP because fast anterograde axonal transport is dis-rupted, and this in turn disrupts axonal function (Figure 34).

There are currently no treatments to slow or reverse HSP. How-ever, regular physical therapy is important for muscle strength and to preserve range of motion.


Hereditary spastic paraple-gia (HSP) – group of inherited

disorders that are characterized by progressive weakness and stiff-

ness of the legs, can be caused by defects in axonal transport.


Figure 33: Mitchell, age 17.

✖ ✖

Figure 34: Hereditary spastic paraple-gia can be caused by mutations within the motor domain of kinesin proteins that are responsible for transporting cargo to the axon terminal.

What are Mitchell’s symptoms? What did his doctor diagnose him with?______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What is the neuronal defect in hereditary spastic paraplegia?________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What does the treatment for hereditary spas-tic paraplegia hope to do?______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________



LESSON READINGDiabetic Neuropathy – Case study of Albert

Albert is 67 years old (Figure 35). He was diagnosed with type II diabetes almost 17 years ago. Despite going on a diet and exercis-ing, Albert has never been able to successfully manage the levels of glucose in his blood, and get them under control, so they still remain high (hyperglycemia). During the last year, Albert noticed a tingling sensation in his feet. Since he is getting older, he did not think much of it. However, when the tingling sensation developed into an actual pain, he called his doctor.

His doctor did a complete examination including testing Albert’s ability to detect sensations in his feet. When Albert did not perform well on this test, she told him he has likely developed diabetic neuropathy, a condition that commonly occurs in patients who have had diabetes for 10 to 20 years. Diabetic neuropathy is a common complication of diabetes, in which nerves are damaged as a result of hyperglycemia.

Diabetic neuropathy can present with any number of symptoms, including tingling or burning sensations in the feet, a deep pain in the arms or legs, muscle cramps, loss of sensitivity to warm or cold, loss of bladder control, and vision changes. The symptoms vary depending on which nerves are affected. Usually feet and legs are affected first, followed by hands and arms. While it is possible to slow diabetic neuropathy by strictly controlling blood glucose levels, diabetes itself is incurable.

Researchers have learned that diabetic neuropathy occurs when the blood supply to nerves is reduced (Figure 36). Over an ex-tended period of time, the high levels of glucose in the blood damage blood vessels. These damaged blood vessels are less able to deliver oxygen to peripheral neurons. Lack of oxygen to nerves reduces their ability to generate ATP. Since fast axonal transport is dependent on ATP, it is particularly vulnerable in dia-betic neuropathy. When axonal transport is compromised, the terminal degenerates, resulting in decreased sensitivity and mo-tor control.

While there is no cure for diabetic neuropathy, the goal of treat-ment is to minimize the symptoms and prevent the disease from getting any worse. It is critically important to control blood glucose levels, and some medications can help reduce the symptoms in the arms and legs.


Diabetic neuropathy – disorder in which nerves of the body are

damaged due to high blood sugar levels resulting from diabetes


Figure 35: Albert, age 67.

Figure 36: Diabetic neuropa-thy. Damage to blood vessels in diabetes results in transport defects because ATP supply to the axons is compromised.

What are Albert’s symptoms? What did his doctor diagnose him with?______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What is the neuronal defect in diabetic neu-ropathy? Would you expect myelinated or unmyelinated nerves to be more affected? How does that explain the symptoms?________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What does the treatment for diabetic neurop-athy hope to do?________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________



LESSON READINGAlzheimer’s disease (AD) – Case study of Yumiko

Yumiko is 66 years old and incredibly forgetful (Figure 37). Lately her family has become very concerned. At a recent family dinner, Yumiko could not remember the name of her favorite dessert – chocolate mousse pie. She also had difficulty remembering how to get home from her son’s house. Then, later that week she had to ask for help to balance her checkbook, something she used to do all the time, often without a calculator.

When Yumiko saw her doctor, she described her symptoms and asked if her family’s worries were reasonable — that her forgetfulness was not normal, but instead something to be concerned about. The doctor asked her a series of questions about her memory, including whether or not she was having difficulty with language, misplacing things, and thinking about abstract topics. He also asked whether or not she had noticed any changes in her mood or behavior. Yumiko didn’t want to admit it, but after being pressed by her daughter she reluc-tantly answered that yes in fact she had been experiencing all of those things to some degree. The doctor told Yumiko that yes, in fact these symptoms, together with her age were cause for further testing. He did a complete physical exam and ordered a thorough neurological exam. The test results ruled out a brain tumor, stroke, and thyroid disease, which all could also cause the symptoms Yumiko was experiencing, so the doctor gave the diagnosis of Alzheimer’s disease (AD).

Alzheimer’s disease is the leading cause of dementia in the elderly. It is estimated that ten percent of peo-ple over 65 have AD, and that fifty percent of those over 85 have the disease. AD affects memory, thinking and behavior. Problems with memory, as well as impairments with language, decision-making ability, judg-ment and personality must be present for the diagnosis to be made. AD is caused by an increased buildup of tangles of neurofilaments within the cell bodies of neurons as well as increased numbers of protein clumps called amyloid plaques at the synapse (Figure 38). Researchers have discovered that when the plaques develop, neurons are not able to communicate with each other. Perhaps due to the accumulation of tangles within the neural cell body, or perhaps due to defects in neuronal signaling, neurons start to die.

Patients with AD often die earlier than normal, although a pa-tient may live anywhere from 3 to 20 years after the diagnosis. The final phase of the disease, in which patients no longer understand language, recognize family members, and are un-able to perform basic activities of daily living, may last from a few months to several years. Death usually occurs from an infection or failure of other body systems. While there is no cure for AD, treatment focuses on slowing the progression of the disease.

You can watch a video about the changes to neurons that we see in Alzheimer’s disease online — click below or see this unit on the student website:

■ Video: Inside the Brain: Unraveling the Mystery of Alzheimer’s Disease

Figure 37: Yumiko, age 67.

Figure 38: Alzheimer’s disease. Alzheimer’s disease results in an buildup of neurofibrillary tangles within f neurons as well as amyloid plaques within the synapse.

What are Yumiko’s symptoms? What did her doctor diagnose him with?______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

What are the neuronal defects in Alzheimer’s disease?________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

If you were designing a drug to treat Alzheim-er’s disease, what would you have it do? When would you start giving the drug?___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________


Alzheimer’s disease (AD) – major cause of dementia in old age, char-acterized by neurofibrillary tangles, amyloid plagues and neuron loss.


http://sites.tufts.edu/greatdiseases/student/neurological-disorders/nd-unit2/multimedia/alzheimers-disease-video/

http://sites.tufts.edu/greatdiseases/student/neurological-disorders/nd-unit2/multimedia/alzheimers-disease-video/



Remember to identify your sources

STUDENT RESPONSES

In the figure below, label the parts of the neuron and list a function for each part. Describe what could possibly go wrong within the different parts of a neuron. What symptoms might a patient display should these problems arise?

_______________________________________________

_______________________________________________

_______________________________________________

_______________________________________________

_______________________________________________

_______________________________________________

_______________________________________________

_______________________________________________

_______________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

_____________________________________________________________________________________________________

lesson 2.5 workbook -...

Documents